What they were paid
Xeris Biopharma Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $12,500 | — | $0 | $0 | $12,500 |
| FY2024 | $50,000 | $121,500 | — | — | $171,500 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xeris Biopharma Holdings, Inc. DEF 14A filed April 23, 2026, accession 0001867096-26-000021, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Xeris Biopharma pays directors a $50,000 cash retainer and $221,500 in RSUs.
The rest of the Xeris Biopharma board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| BJ Bormann | Independent Director | $294,500 |
| Dawn Halkuff | Independent Director | $290,500 |
| Garheng Kong | Independent Director | $281,500 |
| James Brady | Independent Director | $606,984 |
| Jeffrey Sherman | Independent Director | $285,500 |
| John Johnson | Independent Director | $276,500 |
| John Shannon | Director | $0 |
| Marla Persky | Chair of the Board | $326,500 |
The full Xeris Biopharma compensation record
free company briefThis page is one director within Xeris Biopharma's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat